All News

A subgroup of women with advanced endometrial cancer now have a second-line treatment option to turn to after progressing on chemotherapy.

Immunotherapy takes on a new role in treating patients with triple-negative disease.

Just when a patient with cancer is ready to throw in the towel is often when the tide turns.

Save the date! We invite you to join CURE for our next monthly #CureConnect Tweet Chat on Thursday, September 26, at 1 p.m. EST, when we plan on discussing living with cancer.

An innovative technology may catch this common breast cancer treatment complication earlier.

For Prostate Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

For Thyroid Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

This two-time cancer survivor and clutter-clearing author struggles more thoughtfully with clutter since cancer.

Men with castration-sensitive prostate cancer now have an option for when treatment with androgen deprivation therapy alone is not enough.

If you want my money, you'll have to do better than just putting a ribbon on a t-shirt.

From a treatment update from Alex Trebek to possible cancer concerns over a popular heartburn medication, here’s what is making headlines in the cancer space this week.

Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.

Many patients with blood cancers may be candidates for autologous or allogeneic transplant.

One way to leave children a legacy to remember is by equipping them to understand their bodies, thereby helping them to remain healthy.

A recent survey showed that most Americans do not know what cutaneous squamous cell carcinoma is and how severe the disease can be if it advances.

Taking aspirin was found to improve liver function and extend survival among patients with hepatocellular carcinoma – the most common primary liver cancer.

One survivor discusses how to count moments, not months, and enjoy every single minute.

A phase 3 trial showed a 33% reduction in the risk of death when patients were treated with Erleada compared with placebo.

Dr. Thomas Weber has died following a ‘short but fierce’ fight with mantle cell lymphoma.

The combination use of Keytruda and Lenvima is now approved to treat a subset of patients with advanced endometrial cancer.

We all have stress in our lives that takes many different shapes and forms. Giving space to each other to feel, to grieve and to vent is part of community. It's part of friendship, family and faith that we are all in this thing called life together.

Researchers at Roswell Park Comprehensive Cancer Center found a biomarker that may help to determine which patients with hepatocellular carcinoma will respond to treatment with Nexavar, leading to more individualized treatment options.

Keeping copies of both official and personal health records for cancer and other health concerns can be empowering, and practical, for the cancer survivor.

Patients and survivors shared messages of hope and enjoyed an evening of fun at the 11th annual celebration sponsored by Hackensack Meridian Health.

Going back to school after finishing cancer treatment can be exciting yet anxiety-inducing for a child — and a parent. Memorial Sloan Kettering neuropsychologist and child psychologist Stephen Sands has tips to help make the transition smoother.

A two-time cancer survivor explores her thoughts on aging.

Best-selling author V. Gilbert Beers surprises doctors and proves “age is just a number.”

The oral medication Balversa (erdafitinib) shows promise in patients who have FGFR3 gene alterations.